Skip to main content
Download PDF

Prevalence of asthma among children and adolescents in WHO’s Eastern Mediterranean Region: a meta-analysis of over 0.5 million participants

BMC Public Health volume 24, Article number: 2148 (2024) Cite this article

Abstract

Objective

This study aims to evaluate the epidemiology of asthma among children and adolescents in the Eastern Mediterranean Region.

Methods

Exhaustive searches were conducted across databases, including PubMed, Scopus, Web of Knowledge Core Collection, Embase, and Google Scholar. The selection criteria included studies reporting asthma prevalence in individuals aged 0 to 19 years, using validated questionnaires. Data were extracted and synthesized using the DerSimonian and Laird random effects model.

Results

The overall prevalence of asthma in Eastern Mediterranean Regional Office (EMRO) countries, among the 514,468 children and adolescents included in this meta-analysis, was 10.61%, synthesized from 95 studies. Among the countries studied, Qatar exhibited the highest prevalence at 16.69%, followed by Saudi Arabia at 16.57%, Iraq at 16.22%, Oman at 15.20%, and Afghanistan at 14.90%. Adolescents showed a slightly higher prevalence of asthma at 10.10% compared to children at 9.70%. Boys exhibited a higher prevalence at 11.48% compared to girls at 9.75%. Urban areas demonstrated a higher prevalence at 11.27% than rural areas at 8.29%.

Conclusion

Efforts to reduce asthma prevalence in Arab countries and address underdiagnosis in African nations within the EMRO are crucial. Targeted interventions should focus on addressing environmental triggers and improving access to healthcare. Enhanced diagnostic capabilities and healthcare infrastructure are necessary in African countries. Collaborative action is essential to alleviate the asthma burden and promote respiratory health across the EMRO region.

Peer Review reports

Introduction

In recent decades, the prevalence of asthma has increased significantly, becoming a major public health concern, especially among children and teenagers. Asthma, a complex respiratory disorder, is characterized by persistent inflammation of the airways, resulting in recurrent episodes of wheezing, breathlessness, chest tightness, and coughing. These symptoms can significantly impair the quality of life, limit physical activities, and impose a substantial financial burden on healthcare systems and families. While extensive research has explored the prevalence of asthma in different parts of the world, it is evident that several variables contribute significantly to its prevalence [1,2,3,4]. Various factors, including age, sex, economic status, genetics, and exposure to pollutants, have been demonstrated to impact the occurrence and severity of asthma [5]. First, age plays a vital role in determining asthma, as it influences the development and duration of the disease. Asthma usually occurs in childhood and the risk decreases as individuals enter adulthood. However, some asthma attacks may begin in old age or later in life, suggesting age-related differences in their prevalence [6]. Gender is another factor affecting asthma. Many studies have shown that men and women have different rates of asthma. Boys have more asthma in childhood, but this trend often changes with more women in adolescence and adulthood [7]. Economic conditions have also been shown to affect asthma. People from lower socioeconomic backgrounds often face challenges such as poor housing, lack of healthcare and environmental risks. These factors lead to higher rates of asthma in low-income communities [8]. Exposure to air pollution is a well-known risk factor for asthma. Breathing in various environmental irritants and pollutants such as smoking, air pollution, allergies, and occupational exposure can cause and lead to asthma. People living in cities or near industrial areas may be particularly susceptible to asthma due to increased levels of air pollution [9].

The Eastern Mediterranean Regional Office (EMRO) of the World Health Organization (WHO), encompassing a vast area and comprising diverse nations, represents a unique intersection of socio-economic, social, and environmental variables that can influence the prevalence and management of asthma among children and teenagers. With nations extending from high-income countries with progressed healthcare frameworks to those hooking with financial challenges and restricted therapeutic assets, the EMRO Locale gives a complicated embroidered artwork for studying the prevalence of asthma [10,11,12].

The 2013 International Study of Asthma and Allergies in Childhood (ISAAC) Phase Three revealed that the Eastern Mediterranean region had a comparatively lower incidence of asthma symptoms compared to other parts of the world. Specifically, in the 13–14 age group, boys exhibited a prevalence of 10.6%, while girls showed 7.9% for current asthma symptoms [13]. However, despite this lower prevalence, the region still contends with a substantial burden due to the large number of children and adolescents. Previous studies have documented wide variations in asthma prevalence across different countries and areas in the region, ranging from 1.41% to over 20% [14, 15].

Interestingly, there are conflicting findings regarding asthma prevalence in rural areas. For instance, one study suggests a higher prevalence in rural settings than urban ones (20.5% vs. 7.5%), while another indicates lower rates in rural areas compared to urban settings (1.2% vs. 1.9%) [16, 17]. This variation also extends to differences based on gender and location, highlighting a notable research gap.

To address these complexities, this study aims to contribute to our understanding of childhood asthma in the Eastern Mediterranean Region. Our goal is to conduct a thorough review of studies reporting asthma prevalence, providing updated regional and country-specific estimates.

Methods and materials

This manuscript follows the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines for clear reporting of the prevalence of asthma among children and adolescents in WHO’s Eastern Mediterranean Region [18]. Our study is registered in the International Prospective Register of Systematic Reviews (PROSPERO: CRD42023379776).

Search strategy

Data were found using keywords such as asthma, prevalence, epidemiology, children, pediatrics, adolescent, name of the 21 countries located in EMRO including Afghanistan, Bahrain, Djibouti, Egypt, Iran, Iraq, Jordan, Kuwait, Lebanon, Libya, Morocco, Oman, Pakistan, Palestine, Qatar, Saudi Arabia, Somalia, Sudan, Syria, Tunisia, United Arab Emirates, Yemen. Also, the names of big cities of each country were included in the search strategy. We searched PubMed, Scopus, Web of Knowledge Core Collection, Embase, and Google Scholar from their inception until 1 April 2023. Additionally, the search was updated on 23 January to find relevant studies (Appendix A). Finally, citations of the included articles were searched to identify any additional relevant studies.

Inclusion criteria

Studies that investigated the prevalence of asthma in children under the age of 19 were included in this systematic review without restriction to any specific language. Studies used valid and reliable questionnaires to investigate the prevalence of asthma such as the ISAAC questionnaire, were included. The participants were grouped based on their age, with children defined as those between the ages of 0 and 10, and adolescents classified as those aged 11 to 19. In this study, we aimed to encompass all types of observational studies suitable for assessing asthma prevalence, including cross-sectional, panel studies, and cohorts, while excluding review articles, letters to editors, case reports, case-control studies, and case series.

Exclusion criteria

Exclusion criteria for this study included unrelated subjects, research conducted outside the EMRO region to assess asthma prevalence, usage of non-standardized questionnaires, incomplete data, and studies that did not specify the age group. Additionally, review articles and case-control studies were also excluded.

Quality assessment

For quality assessment, we used the Joanna Briggs Institute (JBI) Tool for Prevalence Studies, which contains 9 questions about the sampling frame, sampling method, validity and reliability of the outcome measurement, and statistical analysis of the study. In this checklist, scoring is shown by a scale of “No”, “Yes”, “unclear” and “Not Applicable”. Although there is no reference guide for scoring the checklist questions, we assigned a score of 1 to the “yes” answer, a score of 0.5 to the “unclear” answer, and a score of 0 to the “no” answer for each question. Finally, the Total JBI score was obtained by summing the score obtained from all the answers for a study divided by the total number of questions. Regarding the median JBI score among all studies (0.75) Studies with a total JBI score of 0.75 and higher were considered low-risk studies while studies with a JBI score of less than 0.75 were labeled as high-risk of bias studies. Two reviewers conducted the quality assessment of included studies independently, with any discrepancies resolved through discussion and consensus with a third reviewer.

Data extraction

The current study made use of the data obtained from included articles via a checklist designed for data extraction. This checklist comprises the author’s name, study design, publication year, the score obtained from JBI quality assessment tool, country, city, sample size, overall age range, gender, asthma prevalence in total, and also in the subgroups of gender, age and place of residence. Data extraction was performed by two reviewers independently, followed by a discussion and consensus with a third reviewer to solve discrepancies. The process of checking studies for inclusion, quality assessment, and data extraction was conducted by FF, YS, PN, and GJ, all of whom were involved in all three processes.

Statistical analysis

The prevalence of asthma was determined by calculating a pooled estimate using DerSimonian and Laird random effects model [19]. This model was selected due to its ability to accommodate significant heterogeneity arising from variations in assessment methods, demographics, and geographic factors among included studies, thereby providing a more conservative estimate of prevalence. Furthermore, the random effects model acknowledges that the prevalence of asthma in the EMRO follows a distribution, whereas a fixed effect assumes that there is only one true underlying effect size. The results were reported with a 95% confidence interval obtained through an exact method for calculating confidence intervals. To assess heterogeneity, the I2 threshold was applied. Additionally, a subgroup analysis was conducted to examine variations based on geographical areas, age, gender, year of publication, and place of residence. To identify potential reasons for heterogeneity, meta-regression was employed by considering the sample size and publication years. Publication bias was evaluated using Egger’s test and a Doi plot. To evaluate the potential impact of language differences in the included studies on our results, we conducted a sensitivity analysis excluding non-English studies. Data analysis was performed using the Metaprop and Metan Stata packages.

Results

Search results

In the first stage, 2537 articles were found; 650 duplicate studies were removed and 1887 studies entered the title and abstract screening phase. Finally, 218 studies were selected to read the full text, 95 of which were eligible to be included in the study, and other studies were excluded for reasons such as inappropriate age range, conducting the study in countries located outside the EMRO region, inappropriate study design and lack of reporting required statistics (Fig. 1).

Fig. 1
figure 1

PRISMA flowchart for inclusion process of studies reporting the prevalence of childhood asthma in EMRO

Full size image

Characteristics of included studies

The publication year of the included studies was from 1990 to 2024. A total of 20 countries were included in this meta-analysis. The number of studies included from each country varies, with Iran having the highest number of studies [19], followed by Saudi Arabia [16], Egypt [12], United Arab Emirates [6], Jordan [6] and Pakistan [5]. Some countries have only one study included in the analysis, such as Bahrain and Afghanistan. No study was found from Djibouti and Somalia. One study reported the prevalence of Asthma in both Tunisia and Morocco [20]. Also, one primary international study reporting childhood asthma in the entire EMRO was included in this meta-analysis [13]. Most of the included studies used questionnaires to assess the self-report prevalence of asthma While only 6 studies evaluated the presence of asthma in participants through clinical examinations. The total number of responding participants in the included studies varied from 309 to more than 92,000 individuals. Among the included studies, the study that reported the lowest prevalence of asthma (1%) among children and adolescents was the study of Ahmadiafshar et al., which was conducted in Iran (Zanjan City). The highest asthma prevalence was reported by Alatawi et al., who reported an asthma prevalence of 31.8% in Saudi Arabian participants aged 5–19 years (Appendix, Table B1).

Risk of bias assessment

The mean JBI score of all included studies was 0.93 ± 0.10 with a minimum of 0.55 and a maximum score of 1 )Appendix, Table B2). The risk of bias was low in most of the included studies, so 86 studies (90.53%) had a low risk of bias, and the risk of bias was high in the remaining 9 studies (9.47%).

The overall prevalence of asthma in EMRO countries

The overall prevalence of asthma in the EMRO countries among a total of 514,468 children and adolescents included in this meta-analysis was 10.61% (95% CI: 9.51–11.71; I2: 99.6%; Fig. 2). The country with the highest asthma prevalence was Qatar at 16.69% (95% CI: 7.84–25.54%; I2 = 99.70%), followed closely by Saudi Arabia at 16.57% (95% CI: 14.29–18.86; I2 = 97.40%), and then United Arab Emirates at 12.95% (95% CI: 10.87–15.03; I2 = 94.30%). Iraq (16.22%), Oman (15.20%), and Yemen (14.40%) all fell within the range of 11–16% prevalence rates (Fig. 3). Similarly, Pakistan (13.07%), Kuwait (13.66%), and Libya (12.55%) also had prevalence rates within this range. Bahrain (11.02%), Egypt (8.85%), Jordan (8.24%), and Syria (8.78%) had prevalences ranging from 8 to 11%. Sudan (8.07%) and Morocco (7.76%) had prevalence rates at the lower end of this range. Lebanon (6.64%), Palestine (6.75%), and Tunisia (4.59%) had the lowest prevalence rates, ranging from 4.59 to 6.75%. Iran had one of the lowest prevalence rates at 5.28% (95% CI: 4.38–6.19; I2 = 97.80%).

Fig. 2
figure 2

Forest plot illustrating the prevalence of asthma among children and adolescents in the Eastern Mediterranean Region

Full size image
Fig. 3
figure 3

Geographical variation of asthma prevalence among children and adolescents in the Eastern Mediterranean Region

Full size image
Table 1 Results of subgroup meta-analyses of childhood asthma in EMRO
Full size table

Overall prevalence of asthma according to gender, age and place of residence

The prevalence of asthma in girls was lower than that of boys under study, with the pooled prevalence of asthma among girls in EMRO countries estimated at 9.75% (95% CI: 8.51–10.99; I2: 99.07%), compared to 11.48% (95% CI: 10.18–12.78; I2: 98.47%) in boys (Appendix, Figure C1 & C2). Additionally, the prevalence of asthma differed among different age groups. The pooled prevalence of asthma in children under 10 years old was 9.70% (95% CI: 8.29–11.10; I2: 99.07%), whereas in adolescents aged between 10 and 19 years old, it was slightly higher at 10.10% (95% CI: 8.82–11.38; I2: 98.93%; Figure C3 & C4). Furthermore, the prevalence of asthma varied based on the place of residence. In 13 studies reporting the prevalence of asthma in rural areas, the overall prevalence was 8.29% (95% CI: 6.91–9.68; I2: 96.62%). Conversely, the overall prevalence of asthma in urban areas was estimated to be higher, with a pooled prevalence of 11.27% (95% CI: 9.32–13.22; I2: 98.76%; Figure C5 & C6).

Subgroup analysis based on assessment method, risk of bias, publication year, and sample size

In studies that used clinical examinations to evaluate the prevalence of asthma, the pooled prevalence was found to be 15.81% (95% CI: 7.78–23.85; I2: 100.00%). Conversely, self-reporting resulted in a higher pooled prevalence of asthma, at 10.27% (95% CI: 9.37–11.18; I2: 99.20%). Asthma prevalence among studies with a high risk of bias was 9.986% (95% CI: 6.86–13.11; I2: 99.00%), while among studies with a low risk of bias, it was slightly higher at 10.751% (95% CI: 9.57–11.94; I2: 99.60%).

In terms of publication year, the pooled prevalence of asthma in the 1990s was 10.359% (95% CI: 5.87–14.85; I2: 99.50%) across 4 studies. This prevalence decreased in the 2000s to 10.323% (95% CI: 8.59–12.05; I2: 99.20%) across 30 studies. However, in the 2010s, the prevalence slightly increased to 10.487% (95% CI: 8.62–12.36; I2: 99.70%) across 40 studies. Finally, in the 2020s, the prevalence further increased to 11.646% (95% CI: 9.39–13.9; I2: 99.10%) across 21 studies (Table 1).

Considering sample size, the pooled prevalence of asthma in studies with a sample size greater than 10,000 was 9.549% (95% CI: 5.29–13.8; I2: 99.90%) across 8 studies. For studies with a sample size between 5,000 and 10,000, the pooled prevalence was 9.22% (95% CI: 6.13–12.31; I2: 99.70%) across 11 studies. Finally, studies with a sample size of less than 5,000 showed a pooled prevalence of 10.99% (95% CI: 9.84–12.14; I2: 98.80%) across 76 studies.

Meta-regression results

A total of 94 studies were included in DerSimonian-Laird random effect meta-regression (Table 2). The overall model fit was moderate with an R-squared value of 53.42% indicating that 53.42% of heterogeneity is explained by the variables included in the model. The Wald chi-square test showed that the model as a whole was statistically significant (p < 0.001). In the meta-regression analysis, several variables were examined to assess their impact on the prevalence of asthma across different settings and time periods. Notably, the prevalence of asthma varied significantly across decades, with a substantial increase observed in the 2010s (coefficient: 3.06, p-value: 0.19) and 2020s (coefficient: 3.34, p-value: 0.16) compared to the reference period in the 1990s. Moreover, certain countries exhibited notably higher prevalence rates, particularly Qatar (coefficient: 11.56, p-value: 0.00), Iraq (coefficient: 11.05, p-value: 0.00), and Saudi Arabia (coefficient: 11.14, p-value: 0.00). Conversely, lower prevalence rates were observed in countries such as Iran, where the coefficient for asthma prevalence was not statistically significant compared to the reference. Additionally, the analysis considered the influence of sample size and risk of bias, although the associations were not statistically significant for these factors.

Table 2 Meta-regression results for prevalence of childhood asthma in EMRO
Full size table

Publication bias

Egger’s test results indicated that publication bias may exist in this study (p-value = 0.01), and these findings were consistent with the Doi plot which had an asymmetric shape (Fig. 4). In the nonparametric trim-and-fill analysis of publication bias, 11 studies on the left side were imputed to address potential bias. The observed prevalence was 10.6%, while the adjusted prevalence, including imputed studies, was 9.05%. The sensitivity analysis, which excluded non-English (Persian) studies, yielded results consistent with the main analysis (Figure C7).

Fig. 4
figure 4

Asymmetric Doi plot revealing the probability of publication bias in asthma prevalence among children and adolescents across EMRO countries

Full size image

Discussion

Asthma prevalence in EMRO: unraveling disparities

The overall prevalence of asthma in the Eastern Mediterranean Regional Office (EMRO) countries, as determined by our meta-analysis, was found to be 10.61% (95% CI: 9.51–11.71; I2: 99.6%). This estimate was derived from a comprehensive analysis of data from a total of 514,468 children and adolescents included in the study. Interestingly, our findings reveal a slightly higher prevalence compared to the prevalence reported by Mallol et al. in 2013, which was 9.35%, contrasting with the 8% prevalence of asthma reported by the WHO for the EMRO [13, 112]. This discrepancy may stem from variations in study methodologies, population demographics, or changes in asthma prevalence over time. On the other hand, in conjunction with the Doi plot and trim-and-fill analysis, it’s important to acknowledge that our findings may still be influenced by publication bias, wherein studies reporting higher prevalence rates of asthma are more likely to be published, potentially leading to an overestimation of asthma prevalence in the EMRO countries. One possible explanation for the higher prevalence in our study is that childhood asthma prevalence was relatively higher in the 2020s compared to previous decades, aligning with WHO projections of asthma deaths in the Eastern Mediterranean Region, estimated at 20,000 in 2015 and anticipated to reach 27,000 by 2030 [112].

This study highlights a significant disparity in asthma prevalence between Arab and African countries within the Eastern Mediterranean Regional Office (EMRO) region, suggesting potential discrepancies in reporting and diagnosis practices. The prevalence of asthma in Arab countries, including Qatar, Saudi Arabia, and the United Arab Emirates, exhibited notably higher rates ranging from 12.95 to 16.69%, compared to African countries such as Sudan and Morocco, where prevalence rates fell within the lower range of 7.76–8.07%. Some of this discrepancy may be attributed to underreporting and underdiagnosis of asthma in African countries, as indicated in previous studies, which is consistent with the weaker body of evidence identified in African countries revealed by the current meta-analysis [113, 114].

Urbanization is another factor that might cause a higher prevalence in Arab countries compared to African ones. In our study, we found a significantly higher prevalence of asthma in urban areas compared to rural ones, with rates of 11.27% and 8.29%, respectively. This difference can be attributed to several factors inherent to urban environments, including heightened levels of both indoor and outdoor air pollution, which introduce harmful substances like particulate matter, nitrogen dioxide (NO2), and ozone. Additionally, urban dwellings often face issues related to pest infestations and mold growth, particularly in substandard housing conditions, serving as potent triggers for asthma exacerbations. Moreover, the presence of endotoxins in urban environments, particularly in poorly maintained housing, further compounds the problem. Economic disparities and housing inadequacies prevalent in urban neighborhoods can exacerbate exposure to asthma triggers like pests, mold, and indoor pollutants. Furthermore, the prevalence of obesity and chronic stress, more common among urban children living in poverty, serves to worsen asthma outcomes, underscoring the multifaceted nature of the urban asthma burden [115,116,117,118].

Environmental factors beyond air pollution, like pollen, dust mites, and pet dander, play a significant role in triggering asthma symptoms, contributing to the variation in asthma prevalence observed across different countries [119, 120]. Exposure to dust particles has been implicated in respiratory diseases, including asthma and pneumonia [121]. This is exacerbated by the emergence of new dust source regions in countries such as Iraq, Syria, Jordan, and Saudi Arabia over the last few decades. These regions, characterized by dry river beds (wadis) and lakes, contribute to the proliferation of easily erodible materials, intensifying the occurrence of dust storms [122]. Therefore, these dust storms could also contribute to the disparity in childhood asthma prevalence observed in the region.

Cultural and socioeconomic differences among EMRO countries are a key factor contributing to the diversity observed in studies within the region. One such cultural aspect is the variation in breastfeeding practices. For instance, African nations like Ethiopia (58.2%) and Tanzania (52.6%) demonstrate higher rates of breastfeeding, while countries such as Saudi Arabia (27.6%) and Qatar (24.3%) report notably lower prevalence rates [123,124,125]. A meta-analysis has illuminated the protective impact of breastfeeding against childhood asthma, indicating a potential risk reduction of up to 16%. Thus, it is plausible that a portion of the higher prevalence rates in Arab countries could be attributed to this factor [126]. Exposure to active smoking and passive smoking is strongly associated with pediatric asthma. Children who reported smoking 300 or more cigarettes per year had a relative risk of 3.9 for new-onset asthma compared with nonsmokers. Moreover, children living with either outdoor smokers, where the odds of asthma are 1.27 times higher, or indoor smokers, where the odds rise to 1.46, exhibit elevated risk. Additionally, regular smoking is linked to an increased likelihood of new-onset asthma [127, 128]. The overall median prevalence of secondhand smoking exposure at home reported across eight Sub-Saharan African countries is 13.8% [129]. Notably, in countries like Qatar, Saudi Arabia, Pakistan, and Kuwait, this prevalence was even higher, reaching 19.3%, 26.4%, 34.3%, and 45.8–51.6% respectively [130,131,132,133]. This increased exposure to secondhand smoke may contribute to the elevated prevalence of asthma in these regions, impacting not only children but also pregnant women. Studies indicate that maternal secondhand smoke exposure during pregnancy is associated with an enhanced risk of childhood asthma development [134].

The heterogeneity of asthma prevalence within populations, particularly in regions like the EMRO, may be influenced by a complex interplay of genetic and environmental factors. Genome-Wide Association Studies (GWAS) have unveiled a multitude of genes linked to asthma, shedding light on potential genetic predispositions. For instance, studies such as the GABRIEL study (a multidisciplinary study to identify the genetic and environmental causes of asthma in the European Community) have pinpointed genes on various chromosomes, such as 2, 6, 9, 15, 17, and 22, associated with asthma development. Notably, the Sphingolipid Biosynthesis Regulator 3 (ORMDL3) gene on chromosome 17 has been implicated in childhood-onset asthma, while the Human Leukocyte Antigen DQ (HLA-DQ) gene has been associated with later-onset asthma [135]. These findings underscore the genetic component of asthma susceptibility. However, the manifestation of asthma is not solely dictated by genetic makeup; environmental influences also play a crucial role. Factors like air pollution and tobacco smoke exposure can exacerbate asthma symptoms, particularly in individuals with genetic susceptibilities [136]. This interaction between genetic predispositions and environmental exposures adds complexity to the understanding of asthma heterogeneity, emphasizing the need for comprehensive approaches that consider both genetic and environmental factors in asthma research and healthcare interventions within the EMRO region and beyond.

Insights for future research

While our efforts aimed to elucidate the variance in asthma prevalence across EMRO countries and the associated risk factors, quantifying the specific contribution of these factors to asthma prevalence in each country remains challenging. Tailored strategies should be devised for individual countries to alleviate asthma prevalence effectively. Future research should concentrate on estimating epidemiological measures such as population-attributable fractions to discern the extent to which each factor contributes to asthma prevalence. Additionally, conducting cost-effectiveness analyses will aid in prioritizing strategies aimed at reducing asthma prevalence efficiently.

Limitations

It is essential to acknowledge the limitations of our study when interpreting the results. The included studies exhibited significant heterogeneity, which may affect the overall estimates. Additionally, relying on self-report questionnaires and clinical examinations to assess asthma prevalence may introduce measurement bias and misclassification, potentially affecting the accuracy of our estimates. There is also the possibility of publication bias, where studies with significant findings are more likely to be published, thus potentially skewing the overall prevalence estimates. Although there were no language restrictions, all included studies were either in Persian or English. To assess the potential impact of this language distribution, a sensitivity analysis was conducted to examine whether the increased weight of studies from Iran affected the results. The sensitivity analysis yielded similar findings to the main analysis, underscoring the robustness of our conclusions in this regard. However, the EMRO region consists of countries with diverse socioeconomic, environmental, and healthcare contexts, which may influence prevalence estimates and limit the generalizability of our findings. Furthermore, data availability from some countries may be limited, impacting the representativeness of our analysis for certain regions. Finally, while we examined prevalence trends over different decades, we did not fully explore the potential impact of changes in diagnostic criteria, awareness, and reporting practices over time. Nevertheless, our systematic review and meta-analysis offer valuable insights into the prevalence of asthma among children and adolescents in the EMRO region. These findings contribute to the existing knowledge on this topic and highlight the necessity for further research to explore the complex factors that influence asthma prevalence in this specific area.

Conclusion

Efforts to reduce asthma prevalence in Arab countries and address underdiagnosis in African nations within the EMRO are imperative. In Arab countries with higher asthma rates, interventions must target environmental triggers like air pollution and indoor allergens, alongside improving access to healthcare and raising awareness about asthma management. Concurrently, African countries require improved diagnostic capabilities and healthcare infrastructure to ensure accurate identification and treatment of asthma cases. This necessitates collaborative action among governments, healthcare providers, researchers, and community organizations. By implementing targeted measures, we can alleviate the burden of asthma, enhance respiratory health, and promote equitable access to asthma care across the EMRO region.

Data availability

Data will be made available on request.

Abbreviations

EMRO:

Eastern Mediterranean Regional Office

ISAAC:

International study of asthma and allergies in childhood

WHO:

World health organization

GWAS:

Genome-wide association studies

NO2:

Nitrogen dioxide

JBI:

Joanna Briggs Institute

PRISMA:

Preferred reporting items for systematic reviews and meta-analyses

PROSPERO:

International prospective register of systematic reviews

CI:

Confidence interval

ORMDL3:

Sphingolipid biosynthesis regulator 3

HLA-DQ:

Human leukocyte antigen DQ

References

  1. van den Wijngaart LS, Roukema J, Merkus PJ. The value of spirometry and exercise challenge test to diagnose and monitor children with asthma. Respirol Case Rep. 2015;3(1):25–8.

    Article  PubMed  PubMed Central  Google Scholar 

  2. He Z, Feng J, Xia J, Wu Q, Yang H, Ma Q. Frequency of signs and symptoms in persons with asthma. Respir Care. 2020;65(2):252–64.

    Article  PubMed  Google Scholar 

  3. Inniss LJ. Independent prescribing for a child with a first diagnosis of asthma: a case study. Emerg Nurse. 2022.

  4. Holmes J, O’Neill V, McGarvey LP, Heaney LG. Adverse perception of cough in patients with severe asthma: a discrete choice experiment. ERJ Open Res. 2023;9(1).

  5. Rahimian N, Aghajanpour M, Jouybari L, Ataee P, Fathollahpour A, Lamuch-Deli N, et al. The prevalence of asthma among Iranian children and adolescent: a systematic review and Meta-analysis. Oxid Med Cell Longev. 2021;2021:6671870.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Trivedi M, Denton E. Asthma in children and adults-what are the differences and what can they tell us about Asthma? Front Pediatr. 2019;7:256.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Shah R, Newcomb DC. Sex Bias in Asthma Prevalence and Pathogenesis. Front Immunol. 2018;9:2997.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Perez MF, Coutinho MT. An overview of Health disparities in Asthma. Yale J Biol Med. 2021;94(3):497–507.

    PubMed  PubMed Central  Google Scholar 

  9. Tiotiu AI, Novakova P, Nedeva D, Chong-Neto HJ, Novakova S, Steiropoulos P et al. Impact of Air Pollution on Asthma outcomes. Int J Environ Res Public Health. 2020;17(17).

  10. Crowl AA, Visger CJ, Mansion G, Hand R, Wu HH, Kamari G, et al. Evolution and biogeography of the endemic Roucela complex (Campanulaceae: Campanula) in the Eastern Mediterranean. Ecol Evol. 2015;5(22):5329–43.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Beca-Carretero P, Teichberg M, Winters G, Procaccini G, Reuter H. Projected Rapid Habitat Expansion of Tropical Seagrass Species in the Mediterranean Sea as Climate Change progresses. Front Plant Sci. 2020;11:555376.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Song P, Adeloye D, Salim H, Dos Santos JP, Campbell H, Sheikh A, et al. Global, regional, and national prevalence of asthma in 2019: a systematic analysis and modelling study. J Glob Health. 2022;12:04052.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Mallol J, Crane J, von Mutius E, Odhiambo J, Keil U, Stewart A, et al. The International Study of Asthma and allergies in Childhood (ISAAC) phase three: a global synthesis. Allergol Immunopathol. 2013;41(2):73–85.

    Article  CAS  Google Scholar 

  14. Abd Elmoneim A, Hassan I, Abd Elnaby A, Abou Elmagd A. Epidemiology and outcome of childhood asthma: a clinical study in an Egyptian university medical centre. East Mediterr Health J. 2013;19(6):520–6.

    Article  CAS  PubMed  Google Scholar 

  15. Al-Kubaisy W, Ali SH, Al-Thamiri D. Risk factors for asthma among primary school children in Baghdad. Iraq Saudi Med J. 2005;26(3):460–6.

    PubMed  Google Scholar 

  16. Gohal G, Yassin A, Darraj H, Darraj A, Maghrabi R, Abutalib Y, et al. Prevalence and risk factors of Childhood Asthma in Jazan Region, Saudi Arabia. J Asthma Allergy. 2024;17:33–43.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Vlaski E, Lawson J. Urban–rural differences in asthma prevalence among young adolescents: the role of behavioural and environmental factors. Allergol Immunopathol. 2015;43(2):131–41.

    Article  CAS  Google Scholar 

  18. Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Int J Surg. 2021;88:105906.

    Article  PubMed  Google Scholar 

  19. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177–88.

    Article  CAS  PubMed  Google Scholar 

  20. El Ftouh M, Yassine N, Benkheder A, Bouacha H, Nafti S, Taright S, et al. Paediatric asthma in North Africa: the Asthma insights and reality in the Maghreb (AIRMAG) study. Respir Med. 2009;103(Suppl 2):S21–9.

    Article  PubMed  Google Scholar 

  21. Habibi-Khorasani SAR, Janghorbani M, Gozashti MH, Samareh fekri M. Prevalence of asthma in elementary school children in Kerman in 1999. J Kerman Univ Med Sci. 2002;9(4):184–93.

    Google Scholar 

  22. Bazazi H, Gharagozlou M, Kassai M, Zahmatkesh H, Parsikia A. The prevalence of asthma and allergic disorders among school children in Gorgan. 2007.

  23. Rahimi Rad M, Hejazi M, Behrouzian R. Asthma and other allergic diseases in 13-14-year-old schoolchildren in Urmia: an ISAAC study. EMHJ-Eastern Mediterranean Health Journal, 13 (5), 1005–1016, 2007. 2007.

  24. Najafizadeh K, FADAEIZADEH L, Salek S. Prevalence and severity of asthmatic symptoms in rasht students: a report from ISAAC study. 2008.

  25. Shakurnia A, Assar S, Afra M, Latifi M. Prevalence of asthma among schoolchildren in Ahvaz, Islamic Republic of Iran. EMHJ-Eastern Mediterranean Health Journal, 16 (6), 651–656, 2010. 2010.

  26. Zobeiri M. Prevalence, risk factors and severity of asthma symptoms in children of Kermanshah. IRAN: ISAAC phase I, II; 2011.

    Google Scholar 

  27. Ghaffari J, Mohammadzadeh I, Khalilian A, Rafatpanah H, Mohammadjafari H, Davoudi A. Prevalence of asthma, allergic rhinitis and eczema in elementary schools in Sari (Iran). Caspian J Intern Med. 2012;3(1):372.

    PubMed  PubMed Central  Google Scholar 

  28. Kiadeh SSNH, Fereidouni M, Khozeime AH. Asthma diagnosis and treatment–1025. Prevalence of childhood asthma in small city of Iran: an ISAAC study. World Allergy Organ J. 2013;6:P24–P.

    Article  PubMed Central  Google Scholar 

  29. Farrokhi S, Gheybi MK, Movahhed A, Dehdari R, Gooya M, Keshvari S, et al. Prevalence and risk factors of asthma and allergic diseases in primary schoolchildren living in Bushehr, Iran: phase I, III ISAAC protocol. Iran J Allergy Asthma Immunol. 2014;348:55.

    Google Scholar 

  30. Mortazavi Moghaddam G, Akbari H, Saadatjoo A. Asthma in Iranian schoolchildren: comparison of ISAAC video and written questionnaires. Iran J Med Sci. 2015;30(3):110–4.

    Google Scholar 

  31. Kalmarzi RN, Shekari AH, Tajik M, Ataee P, Homagostar G, Roshani D, et al. The prevalence of Asthma Symptoms in Elementary and Middle School Students in Kurdistan Province, the West of Iran. Int J Pediatr. 2016;4:1323–30.

    Google Scholar 

  32. Mehravar F, Rafiee S, Bazrafshan B, Khodadost M. Prevalence of asthma symptoms in Golestan schoolchildren aged 6–7 and 13–14 years in Northeast Iran. Front Med. 2016;10:345–50.

    Article  PubMed  Google Scholar 

  33. Ghozikali MG, Ansarin K, Naddafi K, Nodehi RN, Yaghmaeian K, Hassanvand MS, et al. Prevalence of asthma and associated factors among male late adolescents in Tabriz, Iran. Environ Sci Pollut Res. 2017;25:2184–93.

    Article  Google Scholar 

  34. Fazlollahi MR, Najmi M, Fallahnezhad M, Sabetkish N, Kazemnejad A, Bidad K, et al. Paediatric asthma prevalence: the first national population-based survey in Iran. Clin Respir J. 2019;13(1):14–22.

    Article  PubMed  Google Scholar 

  35. Ahmadiafshar A, Nourollahi S, Arminpour A, Faghihzadeh S. The prevalence and risk factors of Asthma, allergic Rhinitis, and Eczema in Primary School Children, Zanjan, Iran. J Adv Med Biomedical Res. 2020;28(130):230–6.

    Article  Google Scholar 

  36. Tavakol M, Abhari SMF, Moosaie F, Rasmi M, Bakhtiyari M, Keikavoosi-Arani L et al. Prevalence of asthma symptoms in 13-14-year-old adolescents in Karaj. Iran J Allergy Asthma Immunol. 2020.

  37. Behniafard N, Nafei Z, Mirzaei M, Karimi M, Vakili M. Prevalence and severity of adolescent asthma in Yazd, Iran: based on the 2020 Global Asthma Network (GAN) Survey adolescents Asthma Prevalence in Central Iran. Iran J Allergy Asthma Immunol. 2021;20(1):24.

    PubMed  Google Scholar 

  38. Sabeti Z, Ansarin K, Seyedrezazadeh E, Asghari Jafarabadi M, Zafari V, Dastgiri S, et al. A comparison of asthma prevalence in adolescents living in urban and semi-urban areas in northwestern Iran. Hum Ecol Risk Assessment: Int J. 2021;27(8):2051–68.

    Article  CAS  Google Scholar 

  39. Dastoorpoor M, Khodadadi N, Madadizadeh F, Raji H, Shahidizadeh E, Idani E, et al. Assessing the prevalence and severity of asthma, rhinitis, and eczema among schoolchildren (6–7 and 13–14 years old) in Khuzestan, Iran: a cross-sectional survey. BMC Pediatr. 2022;22(1):1–10.

    Article  Google Scholar 

  40. Bener A, Abdulrazzaq Y, Debuse P, Al-Mutawwa J. Prevalence of asthma among Emirates school children. Eur J Epidemiol. 1994;10:271–8.

    Article  CAS  PubMed  Google Scholar 

  41. Al-Maskari F, Bener A, Al-Kaabi A, Al-Suwaidi NA, Norman N, Brebner J. Asthma and respiratory symptoms among school children in United Arab Emirates. Allerg Immunol. 2000;32 4:159–63.

    Google Scholar 

  42. Alsowaidi S, Abdulle A, Bernsen R. Prevalence and risk factors of asthma among adolescents and their parents in Al-Ain (United Arab Emirates). Respiration. 2009;79(2):105–11.

    Article  PubMed  Google Scholar 

  43. AlBehandy N, Hussein H, Al Faisal W, El Sawaf E, Wasfy A, Alshareef N et al. Prevalence of Bronchial Asthma and Its Association with Obesity and Overweight Among Adolescents in Dubai, UAE. 2015.

  44. Ibrahim NM, Almarzouqi FI, Al Melaih FA, Farouk H, Alsayed M, AlJassim FM. Prevalence of asthma and allergies among children in the United Arab Emirates: a cross-sectional study. World Allergy Organ J. 2021;14(10):100588.

    Article  PubMed  PubMed Central  Google Scholar 

  45. Jamil M, Al Janabi MSY, Francis N, Ali S, Alfalahi A, Ibrahim M. Prevalence of Asthma among High School students in Ajman, Uae: a cross-sectional study. Annals Romanian Soc Cell Biology. 2021;25(6):10843–9.

    Google Scholar 

  46. Hasan MM, Gofin R, Bar-Yishay E. Urbanization and the risk of asthma among schoolchildren in the Palestinian Authority. J Asthma. 2000;37(4):353–60.

    Article  CAS  PubMed  Google Scholar 

  47. El-Sharif N, Abdeen Z, Qasrawi R, Moens G, Nemery B. Asthma prevalence in children living in villages, cities and refugee camps in Palestine. Eur Respir J. 2002;19(6):1026–34.

    Article  CAS  PubMed  Google Scholar 

  48. El-Sharif NA, Nemery B, Barghuthy F, Mortaja S, Qasrawi R, Abdeen Z. Geographical variations of asthma and asthma symptoms among schoolchildren aged 5 to 8 years and 12 to 15 years in Palestine: the International Study of Asthma and allergies in Childhood (ISAAC). Annals of allergy. Asthma Immunol. 2003;90(1):63–71.

    Article  Google Scholar 

  49. Janahi IA, Bener A, Bush A. Prevalence of asthma among Qatari schoolchildren: international study of asthma and allergies in childhood. Qatar Pediatr Pulmonol. 2006;41(1):80–6.

    Article  PubMed  Google Scholar 

  50. Veettil ST, Alnuaimi ASA. Epidemiology and utilization of primary health care services in Qatar by asthmatic children 5–12 years old: secondary data analysis 2016–2017. Asthma Res Pract. 2019;5:1–8.

    Article  Google Scholar 

  51. Hammoudeh S, Hani Y, Alfaki M, Omar N, El Dimassi D, Nowir K, et al. The prevalence of asthma, allergic rhinitis, and eczema among school-aged children in Qatar: A Global Asthma Network Study. Pediatr Pulmonol. 2022;57(6):1440–6.

    Article  PubMed  Google Scholar 

  52. Bouayad Z, Aichane A, Afif A, Benouhoud N, Trombati N, Chan-Yeung M, et al. Prevalence and trend of self-reported asthma and other allergic disease symptoms in Morocco: ISAAC phase I and III. Int J Tuberc Lung Dis. 2006;10(4):371–7.

    CAS  PubMed  Google Scholar 

  53. Al Thamiri D, Al Kubaisy W, Ali S. Asthma prevalence and severity among primary-school children in Baghdad. EMHJ-Eastern Mediterranean Health Journal, 11 (1–2), 79–86, 2005. 2005.

  54. Alsamarai AM, Salih MA, Alobaidy AH, Alwan AM, Abdulaziz ZH. Risk factors for asthma in Iraqi children. J Rural Trop Public Health. 2009;8:45–52.

    Google Scholar 

  55. Al-Kubaisy W, Al–Thamiri D. Pediatric Asthma and its relation to socio-demographic factors in Baghdad. Asian J Environment-Behaviour Stud. 2017;2(4):1–10.

    Article  Google Scholar 

  56. Alsaadi IM, Al-Tawil NG, PREVALENCE, OF, AND, FACTORS ASSOCIATED WITH, ASTHMA AMONG TEENAGER STUDENTS IN ERBIL CITY. Journal of Pharmaceutical Negative Results. 2022:2577-86.

  57. Mustafa G, Khan PA, Iqbal I. Nocturnal asthma in school children of south Punjab Pakistan. J Ayub Med Coll Abbottabad. 2008;20(3):36–9.

    PubMed  Google Scholar 

  58. Hasnain SM, Khan M, Saleem A, Waqar MA. Prevalence of asthma and allergic rhinitis among school children of Karachi, Pakistan, 2007. J Asthma. 2009;46(1):86–90.

    Article  PubMed  Google Scholar 

  59. Khan AA, Tanzil S, Jamali T, Shahid A, Naeem S, Sahito A, et al. Burden of asthma among children in a developing megacity: childhood asthma study, Pakistan. J Asthma. 2014;51(9):891–9.

    Article  PubMed  Google Scholar 

  60. Zahid W, Rozi S, Khan FR, Zahid N, Kadir M. Association between Asthma and Dental Caries amongst 12–15 years Old Children: A School-based cross-sectional study in Karachi, Pakistan. Open J Epidemiol. 2019.

  61. Samoo UG, Ehsan S. Prevalence of asthma and allergic disorders in school children of Karachi. Int J Contemp Pediatr. 2021.

  62. Abuekteish F, Alwash R, Hassan M, Daoud A. Prevalence of asthma and wheeze in primary school children in northern Jordan. Ann Trop Paediatr. 1996;16(3):227–31.

    Article  CAS  PubMed  Google Scholar 

  63. Abu-Ekteish F, Otoom S, Shehabi I, editors. Prevalence of asthma in Jordan: comparison between Bedouins and urban schoolchildren using the International Study of Asthma and Allergies in Childhood phase III protocol. Allergy & Asthma Proceedings; 2009.

  64. Al-Sheyab N, Alomari MA, Shah S, Gallagher P, Gallagher R. Prevalence, patterns and correlates of cigarette smoking in male adolescents in northern Jordan, and the influence of waterpipe use and asthma diagnosis: a descriptive cross-sectional study. Int J Environ Res Public Health. 2014;11(9):9008–23.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  65. Al-Motlaq MA, Al-Sheyab NA. Childhood asthma prevalence and severity in Zarqa city, Jordan. Jordan Med J. 2019;53(3):139–46.

    Google Scholar 

  66. Al-Sheyab NA, Alomari MA. Prevalence, associated factors, and control level of asthma symptoms among adolescents in Northern Jordan. Int J Adolesc Med Health. 2020;32(3).

  67. Nour A, Alsayed AR, Basheti I, editors. Prevalence of asthma amongst schoolchildren in Jordan and staff readiness to help. Healthcare: MDPI; 2023.

    Google Scholar 

  68. Al-Sindi H, Al-Mulla M, Bu-Saibaa A, Al-Sharaf B, Jawad JS, Karim OA. Prevalence of asthma and allergic diseases in children aged 6–7 in the Kingdom of Bahrain. J Bahrain Med Soc. 2014;25(2):71.

    Article  Google Scholar 

  69. Hijazi N, Abalkhail B, Seaton A. Asthma and respiratory symptoms in urban and rural Saudi Arabia. Eur Respir J. 1998;12(1):41–4.

    Article  CAS  PubMed  Google Scholar 

  70. Al-Dawood KM. Epidemiology of bronchial asthma among school boys in Al-Khobar city, Saudi Arabia. Saudi Med J. 2000;22(1):61–6.

    Google Scholar 

  71. Alshehri MA, Abolfotouh MA, Sadeg A, Najjar Y, Asindi AA, Harthi A, et al. Screening for asthma and associated risk factors among urban school boys in Abha city. Saudi Med J. 2000;21(11):1048–53.

    CAS  PubMed  Google Scholar 

  72. Al Frayh A, Shakoor Z, ElRab MG, Hasnain S. Increased prevalence of asthma in Saudi Arabia. Ann Allergy Asthma Immunol. 2001;86(3):292–6.

    Article  CAS  PubMed  Google Scholar 

  73. Al Frayh A. A 17 year trend for the prevalence of asthma and allergic diseases among children in Saudi Arabia. J Allergy Clin Immunol. 2005;115(2):S232.

    Article  Google Scholar 

  74. Al Ghobain MO, Al-Hajjaj MS, Al Moamary MS. Asthma prevalence among 16-to 18-year-old adolescents in Saudi Arabia using the ISAAC questionnaire. BMC Public Health. 2012;12(1):1–5.

    Article  Google Scholar 

  75. Nahhas MA, Bhopal R, Anandan C, Elton R, Sheikh A. Prevalence of allergic disorders among primary school-aged children in Madinah, Saudi Arabia: two-stage cross-sectional survey. PLoS ONE. 2012;7.

  76. Alqahtani JM. Asthma and other allergic diseases among Saudi schoolchildren in Najran: the need for a comprehensive intervention program. Ann Saudi Med. 2016;36(6):379–85.

    Article  PubMed  PubMed Central  Google Scholar 

  77. Khawaji AF, Basudan A, Moafa A, Faqihi M, Alhazmi M, Mahnashi TA, et al. Epidemiology of bronchial asthma among children in Jazan Region, Saudi Arabia. Indian J Allergy Asthma Immunol. 2017;31(2):69.

    Article  Google Scholar 

  78. al-Mutairi AM, Qassim, Almutairi SM, editors. EPIDEMIOLOGY OF BRONCHIAL ASTHMA AMONG PRIMARY SCHOOL CHILDREN IN BURAYDAH2018.

  79. Alruwaili MF, Elwan A. Prevalence of asthma among male 16 to 18-year-old adolescents in the Northern Borders Region of Saudi Arabia. Electron Physician. 2018;10:6920–6.

    Article  PubMed  PubMed Central  Google Scholar 

  80. Fareed M, Meshal MMA, Balood MSA, Halim K. Prevalence of Asthma and allergic symptoms among General Population in Riyadh Region of Saudi Arabia. Int J Med Res Health Sci. 2018;7:121–6.

    Google Scholar 

  81. Alomary SA, Althagafi WA, Al Madani AJ, Adam IF, Elsherif OE, Al-Abdullaah AA, et al. The burden of asthma among children and adolescents in Saudi Arabia: a national cross-sectional survey. J Allergy Clin Immunology: Global. 2022;1(4):241–7.

    Google Scholar 

  82. Alshammrie FF, Albarrak SKA, Alhuthaili AA, Alakash SA, Al Mansour MH, Gammash MR. Prevalence and influencing risk factors of Eczema among Preschool Children in Hail City. Cureus. 2022;14.

  83. Alatawi AM, Alanazi A, Almutairi ABS, Albalawi R, Alhakami AAM, Alnuaman AAS et al. Prevalence and risk factors of allergic diseases among School students in Tabuk: a cross-sectional study. Cureus. 2023;15.

  84. Zedan M, Settin A, Farag M, Ezz-Elregal M, Osman E, Fouda A. Prevalence of bronchial asthma among Egyptian school children. Egypt J Bronchol. 2009;3(2):124–30.

    Google Scholar 

  85. Abdallah AM, Sanusy KA, Said WS, Mahran DG, Mohamed-Hussein AA. Epidemiology of bronchial asthma among preparatory school children in Assiut district. Egypt J Pediatr Allergy Immunol (The). 2012;10(2).

  86. Mansour AE, Yasein YA, Ghandour AA, Zaidan O, El-Abaas MMA, editors. Prevalence of bronchial asthma and its impact on the cognitive functions and academic achievement among preparatory school children in Damietta Governorate, Egypt2014.

  87. Abdel Hafez A, El-Mashad G, Mahmoud A. The prevalence of bronchial asthma among primary school children in Menoufiya Governorate (El-Bagour Center). Menoufia Med J. 2016;29(1).

  88. El Sherbini M, Ata AB, El- Sayed S. Prevalence of asthma and other atopies among school children in Qalyubia Governorate, Egypt. Med Res J. 2016;15:27–33.

    Article  Google Scholar 

  89. Eldin E, El G, Ahmed R, Kamel AS, Amin SA, Hashem AE, editors. Epidemiology of Childhood Asthma in Fayoum City (District) Egypt2016.

  90. Meatty EM, El-Desoky T, El-Domyaty H, El-Gilany A, Nasef N. Prevalence of childhood bronchial asthma and its associated factors: a community based study in Egypt. Progress Med Sci. 2018;2(2):14–20.

    Article  Google Scholar 

  91. Boshra M, Ahmed MM, Raafat D. Prevalence of bronchial asthma in primary school students in Assiut. J Curr Med Res Pract. 2019;4:77–82.

    Article  Google Scholar 

  92. Abdelmotaleb GS, Aldosoky RS, Abdelaaty RI, Abd AL-Hakam HA. Prevalence of childhood bronchial asthma and its risk factors in Kom Hamada district, Beheira Governorate, Egypt. Int J Psychosocial Rehabilitation. 2020;24(10).

  93. Mohammed M, ABDELAKHER AR, SHOKRY DM, SAFAA AE. Prevalence of bronchial asthma among school aged children in Elmaraghah Center in Sohag Governorate. Med J Cairo Univ. 2020;88(June):1097–101.

    Article  Google Scholar 

  94. Sobieh A, Shahin A, Ali M. Prevalence of Childhood Asthma in Preschool Children in Qalyubiya Governorate. Benha J Appl Sci. 2020;5(5 part 1):159–64.

    Google Scholar 

  95. Strannegard IL, Strannegård Ö. Childhood bronchial asthma in a desert country. Allergy. 1990;45(5):327–33.

    Article  CAS  PubMed  Google Scholar 

  96. Behbehani NA, Abal A, Syabbalo N, Abd Azeem A, Shareef E, Al-Momen J. Prevalence of asthma, allergic rhinitis, and eczema in 13-to 14-year-old children in Kuwait: an ISAAC study. Ann Allergy Asthma Immunol. 2000;85(1):58–63.

    Article  CAS  PubMed  Google Scholar 

  97. Owayed A, Behbehani N, Al-Momen J. Changing prevalence of asthma and allergic diseases among Kuwaiti children: an ISAAC study (phase III). Med Principles Pract. 2008;17(4):284–9.

    Article  CAS  Google Scholar 

  98. AL-RIYAMI BM, AL‐RAWAS OA, AL‐RIYAMI AA, Jasim LG, Mohammed AJ. A relatively high prevalence and severity of asthma, allergic rhinitis and atopic eczema in schoolchildren in the Sultanate of Oman. Respirology. 2003;8(1):69–76.

    Article  PubMed  Google Scholar 

  99. Al-Rawas OA, Al-Riyami BM, Al-Kindy H, Al-Maniri AA, Al-Riyami AA. Regional variation in the prevalence of asthma symptoms among Omani school children: comparisons from two nationwide cross-sectional surveys six years apart. Sultan Qaboos Univ Med J. 2008;8(2):157.

    PubMed  PubMed Central  Google Scholar 

  100. Waked M, Salameh P. Asthma, allergic rhinitis and eczema in 13-14-year-old schoolchildren across Lebanon. J Med Liban. 2006;54(4):181–90.

    PubMed  Google Scholar 

  101. Waked M, Salameh P. Asthma, allergic rhinitis and eczema in 5–12-year-old school children across Lebanon. Public Health. 2008;122(9):965–73.

    Article  CAS  PubMed  Google Scholar 

  102. Musharrafieh U, Al-Sahab B, Zaitoun F, El-Hajj MA, Ramadan F, Tamim H. Prevalence of asthma, allergic rhinitis and eczema among Lebanese adolescents. J Asthma. 2009;46(4):382–7.

    Article  PubMed  Google Scholar 

  103. Hallit S, Sacre H, Kheir N, Hallit R, Waked M, Salameh P. Prevalence of asthma, its correlates, and validation of the Pre-school Asthma Risk factors Scale (PS-ARFS) among preschool children in Lebanon. Allergol Immunopathol. 2021;49(1):40–9.

    Article  Google Scholar 

  104. Bahaj S, Moharem A, Kaid A. Prevalence of asthma and allergic diseases among high school students in urban and rural communities, Yemen. Egypt J Med Microbiol. 2012;38:1–5.

    Google Scholar 

  105. Hussein SE, Ahmed MA. Prevalence and risk factors of asthma among Wad Medani basic school children, Gezira State. Sudan J Family Community Med. 2005;12(3):145.

    Article  PubMed  Google Scholar 

  106. Halay S, Balla SA, Elsheikh TAE, Awadalla H, Burbr AA, Hamid EK, et al. Prevalence of Wheezes and Asthma among Preschool Children (1–6 years) in rural Sudan 2016. Int J Trop DISEASE Health. 2018;32(1):1–8.

    Article  Google Scholar 

  107. Sonia T, Meriem M, Yacine O, Nozha BS, Nadia M, Bechir L, et al. Prevalence of asthma and rhinitis in a Tunisian population. Clin Respir J. 2018;12(2):608–15.

    Article  PubMed  Google Scholar 

  108. Bemanin M, Fallahpour M, Arshi S, Nabavi M, Yousofi T, Shariatifar A. First report of asthma prevalence in Afghanistan using international standardized methods. EMHJ-Eastern Mediterranean Health J. 2015;21(3):194–8.

    Article  CAS  Google Scholar 

  109. Ali M, Abduljawad N, Saad A, Al-Zawi A, THE PREVALENCE OF ASTHMA, AND ALLERGIC DISEASES IN SCHOOL AGE CHILDREN IN ALBAYDA-LIBYA. EUROPEAN JOURNAL OF PHARMACEUTICAL AND MEDICAL RESEARCH. 2021;8:194–6.

  110. Mohammad Y, Tabbah K, Mohammad S, Yassine F, Clayton T, Hassan M. International study of asthma and allergies in childhood: phase 3 in the Syrian Arab Republic. EMHJ-Eastern Mediterranean Health Journal, 16 (7), 710–716, 2010. 2010.

  111. Mohammad Y, Rafea S, Latifeh Y, Haydar T, Jamal H, Alkhayer G, et al. Global Asthma Network Phase I Syria Asthma surveillance and the impact of the war. J Thorac Dis. 2023;15(5):2873–81.

    Article  PubMed  PubMed Central  Google Scholar 

  112. Organization WH. Asthma [ https://www.emro.who.int/health-topics/asthma/index.html.

  113. Adeloye D, Chan KY, Rudan I, Campbell H. An estimate of asthma prevalence in Africa: a systematic analysis. Croat Med J. 2013;54(6):519–31.

    Article  PubMed  PubMed Central  Google Scholar 

  114. Ehrlich R, Jordaan E, Du Toit D, Volmink J, Weinberg E, Zwarenstein M. Underrecognition and undertreatment of asthma in Cape Town primary school children. South Afr Med J. 1998;88(8):986–94.

    CAS  Google Scholar 

  115. Anenberg SC, Mohegh A, Goldberg DL, Kerr GH, Brauer M, Burkart K, et al. Long-term trends in urban NO2 concentrations and associated paediatric asthma incidence: estimates from global datasets. Lancet Planet Health. 2022;6(1):e49–58.

    Article  PubMed  Google Scholar 

  116. Balmes JR. The role of ozone exposure in the epidemiology of asthma. Environ Health Perspect. 1993;101(Suppl 4):219–24.

    Article  PubMed  PubMed Central  Google Scholar 

  117. Gern JE. The Urban Environment and Childhood Asthma study. J Allergy Clin Immunol. 2010;125(3):545–9.

    Article  PubMed  PubMed Central  Google Scholar 

  118. Grant TL, Wood RA. The influence of urban exposures and residence on childhood asthma. Pediatr Allergy Immunol. 2022;33(5):e13784.

    Article  PubMed  PubMed Central  Google Scholar 

  119. Rao D, Phipatanakul W. Impact of environmental controls on childhood asthma. Curr Allergy Asthma Rep. 2011;11(5):414–20.

    Article  PubMed  PubMed Central  Google Scholar 

  120. Milián E, Díaz AM. Allergy to house dust mites and asthma. P R Health Sci J. 2004;23(1):47–57.

    PubMed  Google Scholar 

  121. D’Amato G, Akdis CA. Desert dust and respiratory diseases: further insights into the epithelial barrier hypothesis. Allergy. 2022;77(12):3490–2.

    Article  PubMed  Google Scholar 

  122. Francis D, Fonseca R, Nelli N, Bozkurt D, Cuesta J, Bosc E. On the Middle East’s severe dust storms in spring 2022: triggers and impacts. Atmos Environ. 2023;296:119539.

    Article  CAS  Google Scholar 

  123. Bhattacharjee NV, Schaeffer LE, Marczak LB, Ross JM, Swartz SJ, Albright J, et al. Mapping exclusive breastfeeding in Africa between 2000 and 2017. Nat Med. 2019;25(8):1205–12.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  124. Hendaus MA, Alhammadi AH, Khan S, Osman S, Hamad A. Breastfeeding rates and barriers: a report from the state of Qatar. Int J Womens Health. 2018;10:467–75.

    Article  PubMed  PubMed Central  Google Scholar 

  125. Hegazi MA, Allebdi M, Almohammadi M, Alnafie A, Al-Hazmi L, Alyoubi S. Factors associated with exclusive breastfeeding in relation to knowledge, attitude and practice of breastfeeding mothers in Rabigh community, Western Saudi Arabia. World J Pediatr. 2019;15(6):601–9.

    Article  CAS  PubMed  Google Scholar 

  126. Xue M, Dehaas E, Chaudhary N, O’Byrne P, Satia I, Kurmi OP. Breastfeeding and risk of childhood asthma: a systematic review and meta-analysis. ERJ Open Res. 2021;7(4).

  127. Ogbu CE, Ogbu SC, Khadka D, Kirby RS. Childhood asthma and smoking: moderating Effect of Preterm Status and Birth Weight. Cureus. 2021;13(4):e14536.

    PubMed  PubMed Central  Google Scholar 

  128. Gilliland FD, Islam T, Berhane K, Gauderman WJ, McConnell R, Avol E, et al. Regular smoking and asthma incidence in adolescents. Am J Respir Crit Care Med. 2006;174(10):1094–100.

    Article  PubMed  PubMed Central  Google Scholar 

  129. Mbulo L, Palipudi K, Smith T, Owusu D, Williams F, Dean AK, et al. Secondhand smoke exposure inside the home among adults in eight countries in Sub-saharan Africa: global adult Tobacco Survey, 2012–2018. Nicotine Tob Res. 2023;25(4):828–37.

    Article  PubMed  Google Scholar 

  130. AlMulla A, Kouyoumjian S, Maisonneuve P, Cheema S, Mamtani R. Exposure to second-hand tobacco smoke in Qatar: results from a population-based study. East Mediterr Health J. 2022;28(11):813–22.

    Article  PubMed  Google Scholar 

  131. Alzahrani SH. Levels and factors of knowledge about the related health risks of exposure to secondhand smoke among medical students: a cross-sectional study in Jeddah, Saudi Arabia. Tob Induc Dis. 2020;18:88.

    Article  PubMed  PubMed Central  Google Scholar 

  132. Zahra A, Hassan SU, Batool A, Iqbal N, Khatoon F, Atteya M. Prevalence and determinants of second-hand tobacco smoking in Pakistan. East Mediterr Health J. 2022;28(11):805–12.

    Article  PubMed  Google Scholar 

  133. Ziyab AH, Almari M, Al-Taiar A. Exposure to household secondhand smoke among adolescents in Kuwait: results from two school-based cross-sectional studies. Tob Induc Dis. 2020;18:32.

    Article  PubMed  PubMed Central  Google Scholar 

  134. Simons E, To T, Moineddin R, Stieb D, Dell SD. Maternal second-hand smoke exposure in pregnancy is associated with childhood asthma development. J Allergy Clin Immunol Pract. 2014;2(2):201–7.

    Article  PubMed  Google Scholar 

  135. Moffatt MF, Gut IG, Demenais F, Strachan DP, Bouzigon E, Heath S, et al. A large-scale, consortium-based genomewide association study of asthma. N Engl J Med. 2010;363(13):1211–21.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  136. Ranjbar M, Whetstone CE, Omer H, Power L, Cusack RP, Gauvreau GM. The genetic factors of the Airway Epithelium Associated with the Pathology of Asthma. Genes (Basel). 2022;13(10).

Download references

Acknowledgements

This research was part of an internship program funded by the “Health Economics and Finance Research Group - University of Sharjah, Sharjah, United Arab Emirates” and implemented by the West Asian Organization for Cancer Prevention (APOCP’s West Asia Chapter).

Funding

Not applicable.

Author information

Authors and Affiliations

  1. Department of Epidemiology, School of Public Health and Safety, Shahid Beheshti University of Medical Sciences, Tehran, Iran

    Mohammad Reza Taherian, Aram Halimi & Goljamal Jorjani

  2. Medical School, Shahid Beheshti University of Medical Sciences, Tehran, Iran

    Farbod Fatemian, Yaser Soleimani, Parisa Nozari & Alireza Mosavi Jarrahi

  3. Department of Nursing, College of Health Sciences, University of Sharjah, Sharjah, UAE

    Nabeel Al-Yateem

  4. College of Health Sciences, University of Sharjah, Sharjah, UAE

    Amina Al-Marzouqi & Aysha Humid

  5. Student Research Committee, School of Public Health and Safety, Shahid Beheshti University of Medical Sciences, Tehran, Iran

    Mohammad Reza Taherian

  6. Research Center for Social Determinants of Health, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran

    Aram Halimi

  7. Prevention of Cardiovascular Disease Research Center, Department of Epidemiology, School of Public Health and Safety, Shahid Beheshti University of Medical Sciences, Tehran, Iran

    Seyed Saeed Hashemi Nazari

  8. Safety Promotion and Injury Prevention Research Center, Department of Epidemiology, School of Public Health and Safety, Shahid Beheshti University of Medical Sciences, Tehran, Iran

    Seyed Saeed Hashemi Nazari

  9. Department of Health Care Management, College of Health Sciences, University of Sharjah, University of Sharjah, UAE

    Syed Azizur Rahman

Authors
  1. Mohammad Reza Taherian
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Farbod Fatemian
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Aram Halimi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yaser Soleimani
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Goljamal Jorjani
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Parisa Nozari
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Alireza Mosavi Jarrahi
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Seyed Saeed Hashemi Nazari
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Nabeel Al-Yateem
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Amina Al-Marzouqi
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Aysha Humid
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Syed Azizur Rahman
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

Authors’ contributions: MRT (Mohammad Reza Taherian) and AyH (Aysha Humid): conceptualization and investigation. AMJ (Alireza Mosavi-Jarrahi) and SSHN (Seyed Saeed Hashemi Nazari): supervision on data extraction, screening, and quality assessment. MRT: formal analysis. SAR (Syed Azizur Rahman): project administration. FF (Farbod Fatemian), YS (Yaser Soleimani), PN (Parisa Nozari) and GJ (Goljamal Jorjani): data extraction. FF, YS, PN and GJ: screening. FF, YS, PN and GJ: quality assessment. ArH (Aram Halimi), NA (Nabeel Al-Yateem), SAR, and AM (Amina Al-Marzouqi) wrote the initial draft and all other authors edited the manuscript. All authors contributed to the article and approved the submitted version.

Corresponding authors

Correspondence to Aysha Humid or Syed Azizur Rahman.

Ethics declarations

Ethics approval and consent to participate

Not applicable.

Consent for publication

Not applicable.

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary Material 1

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Taherian, M.R., Fatemian, F., Halimi, A. et al. Prevalence of asthma among children and adolescents in WHO’s Eastern Mediterranean Region: a meta-analysis of over 0.5 million participants. BMC Public Health 24, 2148 (2024). https://doi.org/10.1186/s12889-024-18716-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12889-024-18716-2

Keywords

BMC Public Health

ISSN: 1471-2458

Contact us